Financial PerformanceAfya reported a strong quarter supported by solid avg. ticket increase on medical undergrad, ramp-up of ‘Mais Médicos’ and recently acquired units and improving margins on Medical Practice Solutions segment.
Growth StrategyAfya is expected to support above-average growth of 12% until 2028.
Revenue GuidanceAfya revised its net revenue 2024Y guidance up by 3%, following better-than-expected 1H24 performance on Medical Undergrad segment and recently integrated units of UNIMA.